tiotropium

September 19, 2016September 19, 2016

Spiriva Respimat Safely Improves Lung Function in Kids with Asthma, New Study Results Show

Asthma, News

Boehringer Ingelheim recently announced new results showing that Spiriva Respimat (tiotropium bromide) improved lung function in asthmatic children ages 6 to 11. Data also suggested the drug is safe in children ages 6 ... Read more

May 19, 2016May 19, 2016

Phase 3 Drug Improves Lung Function for COPD Patients with Symptoms After Tiotropium

COPD, News

A new phase 3 clinical study conducted by GSK and Innoviva, Inc. shows that Anoro Ellipta significantly improves lung function in people with COPD, compared to another drug called tiotropium.

February 4, 2016February 4, 2016

Study of Particular Asthma Therapy in Black Adults Finds No Added Benefit

Asthma, News

Scientists evaluated the therapeutic options for asthmatic black adults and the possible association between genetic variations and response to treatment. Researchers from the American Academy of Family Physicians (AAFP) National ... Read more

October 28, 2015November 9, 2015

Boehringer’s STIOLTO RESPIMAT Shows Promising Results Clinical Trials

COPD, News

Post-hoc analysis of the TONADO and OTEMTO trials of the 15,000-patient phase III Chronic Obstructive Pulmonary Disease (COPD) clinical trial TOviTO assessing Boehringer Ingelheim‘s STIOLTO RESPIMAT’s efficacy and safety in COPD were recently ... Read more

October 14, 2015October 15, 2015

Researchers Study Tiotropium Preoperative Therapy in Gastric Cancer Patients with COPD

Lung Cancer, News

Gastric cancer is the third most frequent cause of cancer-related death in the world, mostly affecting elderly people. Treating this disease is still difficult, since most patients are diagnosed with ... Read more

September 22, 2015November 6, 2015

Boehringer Ingelheim to Present New Data for COPD, IPF and Asthma at European Respiratory Society International Congress

Asthma, Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim plans to roll out several major presentations focusing for its respiratory disease portfolio at the upcoming European Respiratory Society (ERS) International Congress, September 26-30. The German company is currently ... Read more

September 17, 2015November 6, 2015

FDA Approves SPIRIVA Respimat as Asthma Maintenance Therapy

Asthma, News

One of the world’s leading pharmaceutical companies, Boehringer Ingelheim, has just announced its inhalation spray for COPD, SPIRIVA Respimat (tiotropium bromide), has received approval from the US Food and Drug Administration ... Read more

August 18, 2015November 9, 2015

Boehringer Ingelheim’s Spiolto Respimat Improves Quality of Life in COPD Patients

COPD, News

Boehringer Ingelheim recently announced new positive data on the Phase IIIb OTEMTO® 1 and 2 trials (NCT01964352 and NCT02006732) on Spiolto® Respimat® (tiotropium plus olodaterol) in patients with chronic obstructive ... Read more

August 7, 2015November 6, 2015

Tiotropium Therapy Shown As Safe and Effective Treatment for Adolescents with Asthma

Asthma, News

A study recently published in the journal Annals of Allergy, Asthma and Immunology showed that inhaled tiotropium is a safe and effective therapy for adolescents with moderate to severe asthma. ... Read more

July 1, 2015November 9, 2015

COPD Treatment STIOLTO RESPIMAT Now Available Nationwide

COPD, News

Following the US Food and Drug Administration‘s final approval of Boehringer Ingelheim Pharmaceuticals, Inc.‘s STIOLTO™ RESPIMAT® (tiotropium bromide and olodaterol) Inhalation Spray in May 2015, the company recently announced that patients with ... Read more